Relative importance of borderline and elevated levels of coronary heart disease risk factors

被引:154
作者
Vasan, RS
Sullivan, LM
Wilson, PWF
Sempos, CT
Sundström, J
Kannel, WB
Levy, D
D'Agostino, RB
机构
[1] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
[3] SUNY Buffalo, Buffalo, NY 14260 USA
[4] NHLBI, Bethesda, MD 20892 USA
[5] Boston Univ, Boston, MA 02215 USA
关键词
D O I
10.7326/0003-4819-142-6-200503150-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Clinical trials indicate that a sizable proportion of adults have multiple borderline coronary risk factors and may benefit from treatment. Objective: To estimate the relative and absolute contributions of borderline and elevated risk factors to the population burden of coronary heart disease (CHD) events. Design: A prospective cohort study and a national crosssectional survey. Setting: The Framingham Study and the Third National Health and Nutrition Examination Survey (NHANES III). Participants: White non-Hispanic persons in the Framingham Study and in NHANES III who were between 35 to 74 years of age and had no CHD. Measurements: Occurrence of first CHD events according to 5 major CHD risk factors: blood pressure, low-density lipoprotein and high-density lipoprotein cholesterol levels, glucose intolerance, and smoking. Three categories - optimal, borderline, and elevated-were defined for each risk factor per national guide-lines. Sex-specific 10-year CHD event rates from the Framingham Study were applied to numbers of at-risk individuals estimated from NHANES III and the 2000 U.S. Census. Results: Twenty-six percent of men and 41% of women had at least 1 borderline risk factor in NHANES III. According to estimates, more than 90% of CHD events will occur in individuals with at least 1 elevated risk factor, and approximately 8% will occur in people with only borderline levels of multiple risk factors. Absolute 10-year CHD risk exceeded 10% in men older than age 45 years who had 1 elevated risk factor and 4 or more borderline risk factors and in those who had at least 2 elevated risk factors. In women, absolute CHD risk exceeded 10% only in those older than age 55 years who had at least 3 elevated risk factors. Limitations: The generalizability of the findings to persons of other ethnic backgrounds is unknown. Conclusions: Borderline CHD risk factors alone account for a small proportion of CHD events.
引用
收藏
页码:393 / 402
页数:10
相关论文
共 37 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]  
[Anonymous], 1994, Vital Health Stat 1, P1
[4]   Task force #1 - Magnitude of the prevention problem: Opportunities and challenges [J].
Benjamin, EJ ;
Smith, SC ;
Cooper, RS ;
Hill, MN ;
Luepker, RV .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (04) :588-603
[5]   Epidemiology of smoking-induced cardiovascular disease [J].
Burns, DM .
PROGRESS IN CARDIOVASCULAR DISEASES, 2003, 46 (01) :11-29
[6]  
*CDCP, 1996, NHANES 3 1988 94 REF
[7]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P4
[8]   National Heart, Lung, and Blood Institute workshop on sodium and blood pressure - A critical review of current scientific evidence [J].
Chobanian, AV ;
Hill, M .
HYPERTENSION, 2000, 35 (04) :858-863
[9]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497